|
CENPF expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.39619982242323E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.60889999790382E-08 |
| Normal-vs-Stage2 |
2.05779999999933E-05 |
| Normal-vs-Stage3 |
1.90159999968742E-07 |
| Normal-vs-Stage4 |
7.79149999963202E-07 |
| Stage1-vs-Stage2 |
2.326200E-01 |
| Stage1-vs-Stage3 |
1.561990E-02 |
| Stage1-vs-Stage4 |
6.597000E-04 |
| Stage2-vs-Stage3 |
2.213800E-01 |
| Stage2-vs-Stage4 |
4.362400E-03 |
| Stage3-vs-Stage4 |
3.249700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.5698002593706E-11 |
| Normal-vs-AfricanAmerican |
4.442600E-03 |
| Normal-vs-Asian |
1.530380E-01 |
| Caucasian-vs-AfricanAmerican |
1.860380E-02 |
| Caucasian-vs-Asian |
6.149600E-01 |
| AfricanAmerican-vs-Asian |
3.917400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.15629958333352E-10 |
| Normal-vs-Female |
3.14360000031044E-07 |
| Male-vs-Female |
5.323900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.695600E-03 |
| Normal-vs-Age(41-60Yrs) |
7.42229999683985E-08 |
| Normal-vs-Age(61-80Yrs) |
1.70059999415884E-09 |
| Normal-vs-Age(81-100Yrs) |
1.098020E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.268410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.284800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.174100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.868000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.652020E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.356000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.699800E-03 |
| Normal-vs-Grade 2 |
1.15170000003495E-06 |
| Normal-vs-Grade 3 |
5.9245000016972E-09 |
| Normal-vs-Grade 4 |
1.4143000000022E-06 |
| Grade 1-vs-Grade 2 |
8.623800E-02 |
| Grade 1-vs-Grade 3 |
2.183000E-03 |
| Grade 1-vs-Grade 4 |
1.200310E-04 |
| Grade 2-vs-Grade 3 |
2.001600E-02 |
| Grade 2-vs-Grade 4 |
5.377300E-04 |
| Grade 3-vs-Grade 4 |
3.958100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.15199999999971E-05 |
| Normal-vs-ccB subtype |
1.37669986521871E-10 |
| ccA subtype-vs-ccB subtype |
1.93880999999063E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.08270000134902E-08 |
| Normal-vs-N1 |
2.219800E-03 |
| N0-vs-N1 |
1.663840E-02 |
|
|
